Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,224,138 papers from all fields of science
Search
Sign In
Create Free Account
levocabastine
Known as:
Levocabastinum
, levocabastine [Chemical/Ingredient]
, 1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-4-piperidinecarboxylic acid
Expand
A synthetic piperidine derivative with antihistamine properties. Levocabastine is a second generation histamine-1 receptor antagonist. When applied…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Allergic Conjunctivitis
Histamine H1 Receptor Antagonists [MoA]
levocabastine 0.5 MG/ML Ophthalmic Suspension [Livostin]
Narrower (4)
Bilina
Levocabastine hydrochloride
Livostin
Lvophta
Broader (2)
Histamine H1 Antagonists, Non-Sedating
Piperidines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Once-daily dosing of levocabastine has comparable efficacy to twice-daily dosing in the treatment of allergic rhinitis assessed in an allergen challenge chamber.
R. Murdoch
,
P. Bareille
,
+5 authors
P. Patel
International journal of clinical pharmacology…
2015
Corpus ID: 20023242
OBJECTIVES To test the hypothesis that intranasal levocabastine (LEVO) may provide benefits as a oncedaily treatment in allergic…
Expand
Review
2015
Review
2015
CLASSIFICATION OF SEDATING ANTIHISTAMINES
2015
Corpus ID: 42392327
BACKGROUND Allergic conditions affect about 20-30% of individuals. A survey of hay fever sufferers found, that 54% were self…
Expand
2012
2012
Cost Effectiveness of Emedastine versus Levocabastine in the Treatment of Allergic Conjunctivitis in 7 European Countries
C. G. Pinto
,
A. Lafuma
,
F. Fagnani
,
M. Nuijten
,
G. Berdeaux
PharmacoEconomics (Auckland)
2012
Corpus ID: 36414188
AbstractObjective: To assess the cost effectiveness of emedastine, a new antihistamine, versus levocabastine in the treatment of…
Expand
2005
2005
Eficacia y seguridad de la olopatadina frente a la levocabastina en el tratamiento de la conjuntivitis alérgica estacional
D. C. Sánchez
2005
Corpus ID: 171560328
La conjuntivitis alergica estacional es una de las patologias oculares mas frecuentes, actualmente se dispone de una amplia…
Expand
1998
1998
Levocabastina contra cetirizina en niños con rinitis alérgica perenne
L. A. Osuna
,
R. Caballero
,
M. Cortés
,
I. O. Aldana
1998
Corpus ID: 74368868
OBJECTIVE: To compare the efficacy and safety of levocabastine nasal spray asid cetirizine oral for the treatment of perennial…
Expand
1997
1997
Antazolin/Tetryzolinhaltige Augentropfen im Vergleich zu Levocabastinhaltigen Augentropfen bei akuter allergischer Konjunktivitis
R. Wertheimer1
,
Gabriela Bleßmann2
1997
Corpus ID: 71945833
Hintergrund Patienten und Methoden Ergebnisse Schlußfolgerungen Background Methodes Results Conclusion
1996
1996
BEDARFSORIENTIERTE THERAPIE DER ALLERGISCHEN RHINOKONJUNKTIVITIS MIT DEM TOPISCHEN ANTIHISTAMINIKUM LEVOCABASTIN
J. Spaeth
,
S. Kulkens
,
R. Mosges
1996
Corpus ID: 78486547
Review
1995
Review
1995
Topical levocabastine—a review of therapeutic efficacy compared with topical sodium cromoglycate and oral terfenadine on days with high pollen counts
M. D. Azevedo
Mediators of Inflammation
1995
Corpus ID: 18608739
Levocabastine is a new H1-receptor antagonist specifically developed for the topical treatment of seasonal allergic…
Expand
1994
1994
[Effects levocabastine ophthalmic solution (H1 receptor antagonist) on symptoms of vernal conjunctivitis. A prospective, randomized double-blind study].
E. Graue
Gaceta Médica de México
1994
Corpus ID: 23803872
A double blind, prospective and randomized study was carried out in forty patients with clinical diagnosis of vernal…
Expand
1986
1986
Comparison of levocabastine, a new selective H1-receptor antagonist, and disodium cromoglycate, in a nasal provocation test with allergen.
M. Kolly
,
A. Pécoud
British Journal of Clinical Pharmacology
1986
Corpus ID: 24997854
The effect of intranasal administration of levocabastine, a new selective H1-receptor antagonist, was investigated in a nasal…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE